iN Therapeutics-preview

Intherapeutics

iN Therapeutics

Private

South KoreaHealthcare & Life Scienceshttp://intherapeutics.com

Last Round

VC Round

Feb 4, 2022

Est. Valuation

$36M

Total Funding Raised

$14M

Company Overview

iN Therapeutics is a pharmaceuticals and drug discovery company that develops drugs for patients suffering from intractable neurological diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

ion channel therapeuticsion channel drug discoverydrug discovery platformnon-opioid analgesicchronic pain treatmentneurotherapeuticsNav1.7 inhibitorfirst-in-class drugsclinical-stage biotechdrug licensingcentral nervous systemCNSamyotrophic lateral sclerosisALShearing loss treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

iN Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

iN Therapeutics Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Feb 4, 2022
Series A	Feb 25, 2021

View all Funding Rounds

Key People

Founding team and executive leadership

Chongdeok Park

Chief Executive Officer

Executive Team

SeungBeom Lee

CTO. VP. Director Of Chemistry

Executive Team

iN Therapeutics Investors

Notable investors and investment history

Investor	Rounds
InterVest	VC Round
Timefolio Asset Management	Series A, VC Round
Korea Omega Investment Corp	Series A
Yuanta Investment	Series A, VC Round
E&Venture Partners	VC Round, Series A
Kiwoom Investment	VC Round, Series A
STIC Ventures	VC Round

View all Investors

iN Therapeutics Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

iN Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about iN Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth Korea

Employee Range8

Year Founded2020

Last FundingFeb 4, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.